Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections

Details for Australian Patent Application No. 2009282572 (hide)

Owner SCHERING CORPORATION SOUTHERN RESEARCH INSTITUTE

Inventors Njoroge, F. George; Piwinski, John J.; Shih, Neng-Yang; Kwong, Cecil D.; Ananthan, Subramaniam; Geng, Feng; Kezar III, Hollis S.; Maddry, Joseph A.; Reynolds, Robert C.; Secrist III, John A.

Agent Griffith Hack

Pub. Number AU-A-2009282572

PCT Pub. Number WO2010/022126

Priority 61/090,450 20.08.08 US

Filing date 19 August 2009

Wipo publication date 25 February 2010

International Classifications

C07D 239/50 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/022126 Priority application(s): WO2010/022126

19 May 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 07 Feb 2011 and 08 Apr 2011

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.; Southern Research Institute

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282574-Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections

2009282571-Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections